Research in Immuno-Oncology

Dr. Jonathon Sedgwick, Head of Cancer Immunology and Immune Modulation, explains the ways in which immuno-oncological drugs enable the immune system to fight cancer.

More related content

Dr. Jonathon Sedgwick

Cancer Immunology

Cancer Immunology at Boehringer Ingelheim
Watch the video on

Cancer Immunology at Boehringer Ingelheim

Oncology

Taking Cancer on

At Boehringer Ingelheim, we believe this can be the generation that redefines many cancers as curable diseases. We want to be part of this transformation.

Watch the video on

Taking Cancer on
Working Together in Oncology

Therapeutic Areas

Oncology and Cancer Immunology Research
Read more on

Oncology and Cancer Immunology Research